Medicare Enrolled

Dr. Rahul Dev Polineni, M.D

Hematology & Oncology · Corona, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
320 W 6TH ST, Corona, CA 92882
9518982828
In practice since 2008 (17 years)
NPI: 1235375155 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Polineni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polineni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Polineni

Dr. Rahul Dev Polineni is a hematology & oncology specialist in Corona, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Polineni performed 803 Medicare services across 409 unique beneficiaries.

Between the years covered by Open Payments, Dr. Polineni received a total of $6,005 from 50 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Polineni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 803 Medicare services $6,005 industry payments

Medicare Practice Summary

Medicare Utilization ↗
803
Medicare services
Bottom 46% in CA for hematology & oncology
409
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
388 $118 $380
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
101 $78 $256
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
88 $66 $284
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
61 $97 $414
New patient office visit, complex (60-74 min) 56 $147 $557
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
50 $142 $631
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
21 $80 $256
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $109 $451
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
18 $106 $474
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,005
Total received (2018-2024)
Avg $858/year across 7 years
Top 40% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,814 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$191 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$121
2023
$1,499
2022
$606
2021
$1,710
2020
$1,135
2019
$860
2018
$74

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$53
Novartis Pharmaceuticals Corporation
$45
Incyte Corporation
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,071
PFIZER INC.
$532
GENZYME CORPORATION
$481
Genentech USA, Inc.
$444
Novartis Pharmaceuticals Corporation
$404
Merck Sharp & Dohme Corporation
$340
AstraZeneca Pharmaceuticals LP
$303
Janssen Biotech, Inc.
$232
Eisai Inc.
$212
Astellas Pharma US Inc
$139
Global Blood Therapeutics, Inc.
$123
Karyopharm Therapeutics Inc.
$118
Pharmacyclics LLC, An AbbVie Company
$108
Regeneron Healthcare Solutions, Inc.
$103
Incyte Corporation
$93
Merck Sharp & Dohme LLC
$86
Alexion Pharmaceuticals, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$77
AVEO Pharmaceuticals, Inc.
$61
EMD Serono, Inc.
$59
BeiGene USA, Inc.
$57
Epizyme, Inc.,
$55
Celgene Corporation
$52
Bayer HealthCare Pharmaceuticals Inc.
$52
Ipsen Biopharmaceuticals, Inc
$50
Janssen Scientific Affairs, LLC
$48
Deciphera Pharmaceuticals Inc.
$41
Janssen Pharmaceuticals, Inc
$40
EISAI INC.
$40
Dova Pharmaceuticals
$38
MorphoSys, US Inc.
$35
Exelixis Inc.
$34
Amgen Inc.
$32
Lilly USA, LLC
$31
Dendreon Pharmaceuticals LLC
$29
Clovis Oncology, Inc.
$27
Gilead Sciences, Inc.
$27
SOBI, INC
$26
Kite Pharma, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Agios Pharmaceuticals, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
ADC Therapeutics America, Inc.
$22
Seagen Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
Sobi, Inc
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
Blueprint Medicines Corporation
$12
Foundation Medicine, Inc.
$12
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · Avastin · BOSULIF · BRUKINSA · CABOMETYX · CAMZYOS · CHANTIX · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JYNARQUE · KEYTRUDA · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nplate · Nubeqa · OPDIVO · OXBRYTA · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Rubraca · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAZVERIK · TECENTRIQ · TIBSOVO · Tazverik · Trodelvy · Ultomiris · VERZENIO · VOTRIENT · Venclexta · XARELTO · XPOVIO · XTANDI · Xtandi · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Corona?
Compare hematology & oncology specialists in the Corona area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
153
Per 100K population
6.2
County median income
$89,672
Nearest hospital
CORONA REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Polineni is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Polineni experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Polineni performed 388 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polineni receive payments from pharmaceutical companies?
Yes. Dr. Polineni received a total of $6,005 from 50 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polineni's costs compare to other hematology & oncology specialists in Corona?
Dr. Polineni's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polineni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →